Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7 | American Diabetes Association

Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7

Speaker: Katherine R Tuttle
Session: New Insights in Diabetic Kidney Disease—Clinical and Experimental Studies (With State-of-the-Art Lecture and ADA Presidents' Select Abstract Presentation)
Congress: 79th Scientific Sessions